317 related articles for article (PubMed ID: 31267870)
1. The Synergy between CRISPR and Chemical Engineering.
Lau CH; Tin C
Curr Gene Ther; 2019; 19(3):147-171. PubMed ID: 31267870
[TBL] [Abstract][Full Text] [Related]
2. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
3. Genome Editing: CRISPR-Cas9.
Hoof JB; Nødvig CS; Mortensen UH
Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
Farooq R; Hussain K; Nazir S; Javed MR; Masood N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
Salsman J; Masson JY; Orthwein A; Dellaire G
Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
Muramoto T; Iriki H; Watanabe J; Kawata T
Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
[TBL] [Abstract][Full Text] [Related]
13. An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants.
Statkute E; Wang ECY; Stanton RJ
Hum Gene Ther; 2022 Sep; 33(17-18):990-1001. PubMed ID: 35196879
[TBL] [Abstract][Full Text] [Related]
14. Viral Delivery Systems for CRISPR.
Xu CL; Ruan MZC; Mahajan VB; Tsang SH
Viruses; 2019 Jan; 11(1):. PubMed ID: 30621179
[TBL] [Abstract][Full Text] [Related]
15. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System.
Bai Y; He L; Li P; Xu K; Shao S; Ren C; Liu Z; Wei Z; Zhang Z
G3 (Bethesda); 2016 Apr; 6(4):917-23. PubMed ID: 26869617
[TBL] [Abstract][Full Text] [Related]
16. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
17. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
[TBL] [Abstract][Full Text] [Related]
18. [Application of machine learning in the CRISPR/Cas9 system].
Zhang GS; Yang Y; Zhang LM; Dai XH
Yi Chuan; 2018 Sep; 40(9):704-723. PubMed ID: 30369475
[TBL] [Abstract][Full Text] [Related]
19. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.
Tang N; Zhang Y; Shen Z; Yao Y; Nair V
CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035
[TBL] [Abstract][Full Text] [Related]
20. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
